Martin Gerry, assistant secretary for planning and evaluation, was confirmed Jan. 31. Gerry's and Wilensky's nominations were sent to the Senate floor Jan. 25, following unanimous Finance Committee Endorsement. Steve Kelmar becomes HHS acting assistant secretary for legislation, replacing Gerald Olson. Kelmar was Olson's principal deputy.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.